about
Inhibition of T24 human bladder carcinoma cell migration by RNA interference suppressing the expression of HD-PTPThe tyrosine phosphatase HD-PTP: A novel player in endothelial migrationExpression analysis and modulation by HIV-Tat of the tyrosine phosphatase HD-PTPSilver Nanoparticles in Orthopedic Applications: New Insights on Their Effects on Osteogenic Cells.Conditioned media from microvascular endothelial cells cultured in simulated microgravity inhibit osteoblast activityRegulation and function of TRPM7 in human endothelial cells: TRPM7 as a potential novel regulator of endothelial function.Short- and long-term effects of silver nanoparticles on human microvascular endothelial cellsMagnesium and osteoporosis: current state of knowledge and future research directions.Type I interferons: ancient peptides with still under-discovered anti-cancer properties.Extracellular magnesium and calcium blockers modulate macrophage activity.Culture of human cells in experimental units for spaceflight impacts on their behaviorMagnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin.Silver nanoparticles-induced cytotoxicity requires ERK activation in human bladder carcinoma cells.Effects of supplementation with different Mg salts in cells: is there a clue?The tyrosine phosphatase HD-PTP (PTPN23) is degraded by calpains in a calcium-dependent manner.Blocking the rise of intracellular calcium inhibits the growth of cells cultured in different concentrations of magnesium.The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells.Interleukin 1 alpha is a marker of endothelial cellular senescent.The different expression of TRPM7 and MagT1 impacts on the proliferation of colon carcinoma cells sensitive or resistant to doxorubicinEverolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.HD-PTP inhibits endothelial migration through its interaction with Src.Femtograms of Interferon-γ Suffice to Modulate the Behavior of Jurkat Cells: A New Light in Immunomodulation.Burning magnesium, a sparkle in acute inflammation: gleams from experimental models.Single cell versus large population analysis: cell variability in elemental intracellular concentration and distribution.Serum magnesium and calcium levels in infertile women during a cycle of reproductive assistance.Impact of simulated microgravity on human bone stem cells: New hints for space medicine.N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells.Extracellular Mg concentration and Ca blockers modulate the initial steps of the response of Th2 lymphocytes in co-culture with macrophages and dendritic cells.Magnesium Deprivation Potentiates Human Mesenchymal Stem Cell Transcriptional Remodeling.Effects of human recombinant type I IFNs (IFN-α2b and IFN-β1a) on growth and migration of primary endometrial stromal cells from women with deeply infiltrating endometriosis: A preliminary studyTRPM7 and MagT1 in the osteogenic differentiation of human mesenchymal stem cells in vitroMagnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D₃Potential interplay between NFκB and PPARγ in human dermal microvascular endothelial cells cultured in low magnesiumThe Contribution of EDF1 to PPARγ Transcriptional Activation in VEGF-Treated Human Endothelial CellsConcentration-Dependent Effects of N-3 Long-Chain Fatty Acids on Na,K-ATPase Activity in Human Endothelial CellsMitophagy contributes to endothelial adaptation to simulated microgravityThe simultaneous downregulation of TRPM7 and MagT1 in human mesenchymal stem cells in vitro: Effects on growth and osteogenic differentiation3D Quantitative and Ultrastructural Analysis of Mitochondria in a Model of Doxorubicin Sensitive and Resistant Human Colon Carcinoma CellsChemical Fingerprint of Zn-Hydroxyapatite in the Early Stages of Osteogenic DifferentiationN6-isopentenyladenosine a new potential anti-angiogenic compound that targets human microvascular endothelial cells in vitro
P50
Q24319159-AD8C0A5B-C30C-4FBD-94EC-B6DFF7CFCC8CQ28254566-60F8CA7F-7F3C-4527-BC84-761E47E0B468Q28291410-EC081DCF-F653-4CEB-B858-C418CB8028B6Q33837864-54A2F037-54F8-4485-9D08-9654CF4C6F10Q34125663-4EF36BE8-2CC3-4F4F-9E0C-C79DFC472F30Q34637991-0EC988D8-1C14-4885-ADF2-161948EA9134Q35451168-AAE66BC6-9310-411A-8A43-FEBB13C333B9Q37177394-18CA02BC-5865-4EDB-A2FF-520B5279FEB8Q38046902-1A5B4BD3-9988-4358-829D-61F34BCDE99FQ38772217-7C42525C-DFAF-492C-A345-38E32D047004Q38793045-D4914693-2872-42C4-9170-C00346E6B970Q38819783-3C2E61AF-0B1F-4EA4-AC15-4A81D2B2343CQ38856048-7F05F665-CFB3-4860-82CC-EBF4D64848F3Q39000708-0189D887-98DB-40BE-AB71-159D40B0ADC2Q39363284-995E146D-C1E3-47EF-B50E-57037A9B5422Q39372726-7BB140EA-3C36-4A55-894D-1445A37E2843Q39483665-FDDE76A1-C6A6-4B5F-B7F1-281BD19DC444Q41676538-0E05A7E6-CF7A-4EB8-9A73-E6737908D004Q42263832-C908C583-8C41-460B-B2A3-A55B6427E550Q42914109-402F35F4-3831-4C20-BA0C-D7E42B9E9E4CQ46398242-F65FF173-9B21-433F-ADC5-B6669FB7A757Q47303771-42D2D41A-1BA0-47ED-91C3-8E2FCC3E78ABQ47924618-23C0E716-1D53-4927-9230-796451F13D23Q49908623-80DB63F2-65CF-4450-BE85-39F1FFFD776DQ50225971-2C3AC4C4-9CD8-4E45-9589-BAC13C04C692Q51423120-7F873EE3-566E-4C25-85F0-53B7EB56CED6Q52631082-D28CCC58-2503-4325-AEC9-D94493CEBE16Q53465142-DFB7B4BC-8C90-465F-B6BC-8BE4CE55606CQ55263627-1951B0F4-8077-4D0D-935C-A8AFD4A96787Q57484511-C26F3795-5E40-4E16-9378-264A0CBE0FF4Q58577628-BDC44151-9E68-47F1-A0C9-FBA7D3BC8461Q61814442-60DD9E37-AD37-4F15-A2EA-3EE0CC38B5CCQ85357400-787A679A-5CD4-4668-9AD6-A020033E2F65Q89200819-E305CE5E-11D8-41CA-89E1-89A71683BEF4Q92441652-7692BC8A-0A4D-45DA-BB3A-7B0D0A4BEC3FQ92498969-E7122543-84DC-4ACF-9A99-0719E1213292Q92882913-9EC1BF8F-3FAD-4157-AA41-9BC7BD6DAAE6Q92959991-7F471E74-E3F9-40A2-B2CE-E5B9DFFAF936Q93089181-8477E7FD-CBB4-4227-979C-89B47CF3C5A7Q93348345-B724CE30-529C-4ED2-8B96-82B8181D45B9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sara Castiglioni
@ast
Sara Castiglioni
@en
Sara Castiglioni
@es
Sara Castiglioni
@nl
type
label
Sara Castiglioni
@ast
Sara Castiglioni
@en
Sara Castiglioni
@es
Sara Castiglioni
@nl
prefLabel
Sara Castiglioni
@ast
Sara Castiglioni
@en
Sara Castiglioni
@es
Sara Castiglioni
@nl
P106
P1153
55583571200
P21
P31
P496
0000-0002-8785-9891